Ruben Mesa, Md Discusses Supportive Care For Myelofibrosis Patients

Ruben Mesa, MD Discusses Supportive Care for Myelofibrosis Patients

Rare Disease Report

Ruben Mesa, MD on Myelofibrosis (Full Interview)

Rare Disease Report

Ruben Mesa, MD Discusses Pathophysiology and Treatment of Myelofibrosis

Rare Disease Report

For Myelofibrosis Patients: The Latest on Promising Treatments from Top Specialist | Dr. Ruben Mesa

The Patient Story

Ruben Mesa, MD: Ruxolitinib as a Myelofibrosis Treatment

Dr Ruben Mesa-Myelofibrosis and Advancing MPNs: Current and Future Approaches

MPN Advocacy & Education International

Ruben Mesa, MD: Myelofibrosis Patients Frequently Present Symptoms

Dr. Ruben Mesa Discusses ASCO 2023 Updates from the SIMPLIFY Trials in Myelofibrosis

Ruben A. Mesa, MD: Treating Myelofibrosis After Ruxolitinib “Failure”

American Society of Hematology

ASH Impact Series: Ruben Mesa, MD - Examining the Current Role of Ruxolitinib in Myelofibrosis

American Society of Hematology

Dr Ruben Mesa Outlines the Quality of Life Impact of Myelofibrosis

Dr. Ruben Mesa, MD- Individualized Treatment Plans for MPNs

MPN Advocacy and Education

Dr Ruben Mesa Discusses Better Understanding Symptoms in MPNs

Ruben Mesa, MD - The History of MPNs

MPN Advocacy & Education International

What Setting Should Clinicians Use Fedratinib to Treat Patients With Myelofibrosis?

Blood Cancers Today

Origins and treatment options for anemia in myelofibrosis

VJHemOnc – Video Journal of Hematology & HemOnc

To JAKi or not to JAKi - treating early MF

VJHemOnc – Video Journal of Hematology & HemOnc

Dr. Ruben Mesa on COMFORT-1 for Myelofibrosis

Dr. Mesa on the Utility of Fedratinib for Patients With Myelofibrosis Who Progress on Ruxolitinib

Ruben Mesa, MD Discusses His Phase 3 Study

Rare Disease Report